<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Dimethyl sulfoxide (DMSO), N-formyl-methionine-leucine-phenylalanine (
 <italic class="italic">f</italic>MLF), PMA, SOD from bovine erythrocytes, and Histopaque 1077 were purchased from Sigma-Aldrich Chemical Co. (St. Louis, MO, USA). Fluo-4AM was from Invitrogen (Carlsbad, CA, USA). 8-Amino-5-chloro-7-phenylpyridol[3,4-d]pyridazine-1,4(2
 <italic class="italic">H</italic>,3
 <italic class="italic">H</italic>)-dione (L-012) was from Wako Chemicals (Richmond, VA, USA). PI3K inhibitors (PI 3065, TGX 221, AS 605240, and A66) and the specific TRPV1 antagonist SB 366791 were from Tocris Bioscience (Minneapolis, MN, USA). Fluo-4AM was from Invitrogen (Carlsbad, CA, USA). The penicillin–streptomycin solution was from Mediatech (Herndon, VA, USA). Fetal bovine serum was from Atlas Biologicals (Fort Collins, CO, USA). Hanks’ balanced salt solution (HBSS; 0.137 M NaCl, 5.4 mM KCl, 0.25 mM Na
 <sub class="sub">2</sub>HPO
 <sub class="sub">4</sub>, 0.44 mM KH
 <sub class="sub">2</sub>PO
 <sub class="sub">4</sub>, 4.2 mM NaHCO
 <sub class="sub">3</sub>, 5.56 mM glucose, and 10 mM HEPES, pH 7.4) was from Life Technologies (Grand Island, NY, USA). HBSS without Ca
 <sup class="sup">2+</sup> and Mg
 <sup class="sup">2+</sup> is designated as HBSS
 <sup class="sup">−</sup>; HBSS containing 1.3 mM CaCl
 <sub class="sub">2</sub> and 1.0 mM MgSO
 <sub class="sub">4</sub> is designated as HBSS
 <sup class="sup">+</sup>.
</p>
